Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses - Related Studies

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

This study is ongoing, but not recruiting participants.

Study NCT00027976. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Keratosis
		Precancerous Conditions

3	More general conditions related to this trial
		Neoplasms
		Skin Diseases

4	Interventions listed in this trial
		celecoxib

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
		National Cancer Institute (NCI)